Frontiers | The Limitless Future of RNA Therapeutics
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses: Molecular Therapy
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
Michael Hogan - Co-Founder & Chief Scientific Officer @ PathogenDx - Crunchbase Person Profile
Preparation of selective organ-targeting (SORT) lipid nanoparticles (LNPs) using multiple technical methods for tissue-specific mRNA delivery | Nature Protocols
Michael Hogan, Ph.D. - Vice-President for PepsiCo Foods North America Procurement - PepsiCo | LinkedIn
Michael Hogan - Postdoctoral Research Fellow - Children's Hospital of Philadelphia | LinkedIn
The 'anti-hype' vaccine | Nature Biotechnology
A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-C
Michael Hogan, PhD
Machine Learning for Designing Next-Generation mRNA Therapeutics | Accounts of Chemical Research
Moderna Drops After Losing Appeal Over Drug-Delivery Patents (2)
Frontiers | Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report
Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines | ACS Central Science
SARS-CoV-2 Vaccine Development: An Overview and Perspectives | ACS Pharmacology & Translational Science
Distinct antibody and memory B cell responses in SARS-CoV-2 naïve and recovered individuals after mRNA vaccination | Science Immunology
Michael Hogan - Senior Advisor - The Regulatory Assistance Project | LinkedIn
Nanotechnology for COVID-19: Therapeutics and Vaccine Research | ACS Nano
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action | npj Vaccines
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
Polymers Strive for Accuracy: From Sequence-Defined Polymers to mRNA Vaccines against COVID-19 and Polymers in Nucleic Acid Therapeutics | Journal of the American Chemical Society
mRNA vaccine - Wikipedia
Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic - Wang - 2022 - Exploration - Wiley Online Library
